Placental cell therapy to prevent kidney injury after heart surgery
Part of Heart & circulation, Kidney & urinary clinical trials.
This trial tests a new treatment using donated placental cells given through an IV to prevent kidney injury after heart bypass surgery. It is for people at high risk of kidney damage because of the surgery.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 45 years or older.
- You are scheduled for heart bypass surgery that will use a heart-lung machine for at least 1 hour.
- Your kidney function is not severely reduced (eGFR above 30) and your kidneys are normal size.
- You do not have active bleeding, a bleeding disorder, or take blood thinners that would put you at risk.
- You have not had certain recent emergencies like a heart attack or sepsis.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a device called RenalGuard to see if it can prevent acute kidney injury in people having heart surgery. If you are at higher risk for kidney problems, this treatment might help protect your kidneys during and after surgery.
This study tests a new drug (ENN0403) given during heart surgery to see if it prevents acute kidney injury—a sudden drop in kidney function. The trial is for people who are already at higher risk due to their specific heart surgery and other health factors.
This trial looks at whether a specific heart-surgery technique (called CLCVP) can help protect kidney function soon after surgery. It is mainly for adults with otherwise normal kidney tests before certain types of heart operations.
This Phase 2 trial tests an LSALT peptide given around the time of “on-pump” heart surgery to help prevent or reduce acute kidney injury (a sudden drop in kidney function). It may help people who are at higher risk for kidney injury during or after surgery.
This trial tests a drug called SP16 to see if it can prevent acute kidney injury in people with chronic kidney disease who are having elective heart surgery with a heart-lung machine. It aims to help preserve kidney function after surgery.
This study tests whether a drug called R2R01 can help protect your kidneys during major heart surgery. Heart surgery can sometimes damage the kidneys, and this trial is looking to see if this new medication reduces that risk.
Hear when a new Preemptive Therapy of Patients At Risk for Acute Kidney Injury Following Cardiac Surgery trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.